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Plasma concentrations of coffee polyphenols and plasma
biomarkers of diabetes risk in healthy Japanese women
AH Lee1, L’B Tan1, N Hiramatsu2, A Ishisaka2, H Alfonso1, A Tanaka3, N Uemura2, Y Fujiwara2 and R Takechi1,3,4
Coffee consumption has been reported to reduce the risk of type 2 diabetes in experimental and epidemiological studies. This anti-
diabetic effect of coffee may be attributed to its high content in polyphenols especially caffeic acid and chlorogenic acid. However, the
association between plasma coffee polyphenols and diabetic risks has never been investigated in the literature. In this study, fasting
plasma samples were collected from 57 generally healthy females aged 38–73 (mean 52, s.d. 8) years recruited in Himeji, Japan. The
concentrations of plasma coffee polyphenols were determined by liquid chromatography coupled with mass tandem spectrometer.
Diabetes biomarkers in the plasma/serum samples were analysed by a commercial diagnostic laboratory. Statistical associations were
assessed using Spearman’s correlation coefficients. The results showed that plasma chlorogenic acid exhibited negative associations
with fasting blood glucose, glycated hemoglobin and C-reactive protein, whereas plasma total coffee polyphenol and plasma caffeic
acid were weakly associated with these biomarkers. Our preliminary data support previous findings that coffee polyphenols have anti-
diabetic effects but further replications with large samples of both genders are recommended.
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INTRODUCTION
Coffee consumption has been reported to reduce the risk of type
2 diabetes in clinical and epidemiological studies. A recent meta-
analysis of 28 prospective cohort studies concluded that the
intake of caffeinated or decaffeinated coffee can reduce the
diabetes risk in a dose-response manner, with one-third risk
reduction by drinking six cups of coffee daily.1 Meanwhile,
experimental studies have suggested that the polyphenols in
coffee may have an important contributing role. In an animal
study using wild-type mice, coffee polyphenols significantly
increased gut-derived active glucagon-like peptide-1 secretion
through increased intracellular cyclic AMP.2 Recently, an extract
of coffee polyphenols was found to improve postprandial
hyperglycemia and decrease oxidative stress in healthy male
subjects.3 Nevertheless, the bioavailability and metabolism of
coffee polyphenols are known to vary between individuals;
as such, the plasma concentration of coffee polyphenols may
more accurately reflect the ‘net exposure’ of tissues and cells
to these polyphenols than the estimated coffee intake.4 To date,
there has been no report on the apparent association between
coffee polyphenols in circulation and plasma biomarkers of type
2 diabetes in healthy population. Therefore, the present study
aimed to determine the plasma concentrations of caffeic acid
and chlorogenic acid, the two major and most abundant coffee
polyphenols, in generally healthy subjects, and to assess their
association with the plasma biomarkers of diabetes risk.
Japanese women were investigated in view of their relatively
high consumption of coffee, and coffee polyphenols provide a
major source of antioxidants in the Japanese population.5
MATERIALS AND METHODS
Subjects
Sixty generally healthy Japanese women aged 38–73 years were
recruited from Tsunashimakai Kosei Hospital and University of
Hyogo in Himeji, Hyogo Prefecture of Japan, during April–August
2014. Exclusion criteria were current prescription for a chronic
condition and diet modification within the past year. Informed
written consent was obtained from all participants. The study
protocol was approved by the Curtin University Human Research
Ethics Committee (approval no. 4649) and University of Hyogo
Research Ethics Committee (approval no. 068).
Sample collection and measurement of biomarkers
Subjects were fasted overnight for more than 8 h before their blood
samples being taken by a qualified phlebotomist. Plasma and serum
samples were then stored at − 80 °C until analysis. Anthropometric
data and blood pressure were also measured before the blood
sample collection. Body fat percentage was measured using a body
composition scale (Tanita, Tokyo, Japan). Plasma glucose, glycated
hemoglobin (HbA1c), insulin, adiponectin and C-reactive protein
(CRP) were measured by a commercial diagnostic laboratory (Falco
Biosystems, Hyogo, Japan).
The concentrations of caffeic acid and chlorogenic acid in plasma
were determined by a highly sensitive technique using high
performance liquid chromatography (HPLC; Agilent 1100LC with
binary pump) (Agilent Technologies, Santa Clara, CA, USA) coupled
with tandem mass spectrometer (MS/MS; Applied Biosystems Sciex
API 3000, Waltham, MA, USA), as described elsewhere with minor
modifications.6–9 Briefly, 500 μl of plasma was mixed with 20 μl of
1School of Public Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia; 2School of Human Science and Environment, University of Hyogo,
Himeji, Japan; 3Nutrition Clinic, Kagawa Nutrition University, Tokyo, Japan and 4Curtin Health Innovation Research Institute, Curtin University, Perth, Western Australia, Australia.
Correspondence: Dr R Takechi, School of Public Health, Faculty of Health Sciences, Curtin University, GPO Box U1987, Perth, Western Australia 6845, Australia.
E-mail: R.Takechi@curtin.edu.au
Received 29 November 2015; revised 13 February 2016; accepted 27 April 2016
Citation: Nutrition & Diabetes (2016) 6, e212; doi:10.1038/nutd.2016.19
www.nature.com/nutd
10% ascorbic acid (w/w in water) and 100 μl of 1% sulfatase H-1
(w/w in pH 5 sodium acetate buffer). After an enzymatic hydrolysis
at 37 °C for 45 min, 2.5 μl of 40 μM ethyl gallate was added as an
internal standard. Caffeic acid and chlorogenic acid were
then extracted with 500 μl of 0.1% formic acid (v/v in ethyl acetate).
The extraction process was repeated three times, and the pooled
extract was evaporated under vacuum (Tomy CC-105 centrifugal
concentrator, CS Bio, Menlo Park, CA, USA and Eyela Unitrap
UT-2000 evaporator, Tokyo, Japan). Samples were reconstituted in
15% acetonitrile and 0.1% formic acid and then centrifuged at
15 000 g at 4 °C for 5 min. A total of 80 μl of the supernatant was
transferred into HPLC-autosampler vials.
Five microliter of sample was next injected into Develosil ODS-SR
C18, 5 μm, 2×150 mm column (Nomura Chemical) with binary
gradient of 0.1% formic acid in ultrapure water (A) and 0.1% formic
acid in acetonitrile (B) at a constant flow rate of 0.2 ml min−1. The
gradient program began at 15% solvent B, increasing to 25% by
10 min and to 50% by 14min, before returning to 15% which was
held for 10 min. The MS/MS was operated with electrospray
ionization in negative mode. The ion spray potential was − 4500 V,
and the source temperature was set at 450 °C.
Caffeic acid, chlorogenic acid and ethyl gallate, purchased from
Sigma-Aldrich (St Louis, MO, USA), were used as a standard. The peak
of each compound was identified based on a comparison of its
retention times and mass spectral data with the corresponding
standard and published data using the ABSCiex Analyse v1.6
software6–9 (Supplementary Figure 1A). All samples were measured
in duplicates.
Statistical analysis
All data were managed via Microsoft Excel. ‘Total coffee polyphenol’
was defined as the sum of caffeic acid and chlorogenic acid
concentrations. In view of the observed non-normal distributions of
the coffee polyphenol variables, the nonparametric Spearman’s rank
correlation method was applied to ascertain the strength of their
association with the diabetes biomarkers. Statistical significance was
taken at Po0.05.
RESULTS
Of the 60 healthy women recruited who met the selection criteria,
57 (95%) completed the study. Table 1 summarizes characteristics
of the participants, together with their mean plasma levels of
glucose, HbA1c, insulin, adiponectin and CRP, as well as their
mean plasma concentrations of caffeic acid and chlorogenic acid.
Table 2 shows the Spearman’s correlation coefficients between
plasma coffee polyphenols and biomarkers of diabetes. Plasma
chlorogenic acid was negatively associated with fasting blood
glucose, HbA1c and CRP, though the strength of the association was
only weak to moderate (Supplementary Figure 1B). For plasma total
coffee polyphenol and caffeic acid, weak associations were found
with the diabetes biomarkers. No significant association (r=0.10,
P= 0.44) was observed between plasma chlorogenic acid and caffeic
acid concentrations (Supplementary Figure 1C).
DISCUSSION
Epidemiological and population studies have demonstrated promis-
ing effects of coffee consumption on reducing the diabetes risk.
Such beneficial effects of coffee may be due to its high content in
anti-oxidative polyphenols. Our results, based on healthy Japanese
women, showed negative associations between chlorogenic acid
and fasting glucose and HbA1c. Chlorogenic acid has been reported
to downregulate fasting glucose and plasma glucose peak in
the oral glucose tolerance test by attenuating intestinal glucose
absorption.10 A study using murine model of diabetes revealed that
chlorogenic acid can reduce fasting plasma glucose and HbA1c by
modulating the adiponectin receptor signaling pathways.11 How-
ever, our data indicated little association between chlorogenic acid
and adiponectin, and similarly for insulin, in contrast to previous
reports that chlorogenic acid can increase insulin secretion.12,13
It should be remarked that these experimental studies were
conducted using in vitro islets cells of rat pancreas or glucose
tolerance test in healthy subjects. Therefore, the effect of
chlorogenic acid may not be apparent on fasting plasma insulin
among healthy individuals.
The observed significant negative association between
chlorogenic acid and CRP is consistent with the literature. In
dietary-induced insulin-resistant mouse model, chlorogenic acid
attenuated inflammation through decreased mRNA encoding
inflammatory cytokines such as Tnfα.14 Furthermore, chlorogenic
acid reduced TNF-α (tumor necrosis factor α), interleukin (IL)-1β
and IL-6 production through attenuating toll-like receptor-
mediated NF-κB signaling pathway.15
Interestingly, only weak associations with diabetes biomarkers
were observed for caffeic acid, despite its mean plasma
concentration was 430-fold greater than chlorogenic acid.
Together with the low correlation between plasma caffeic acid
and chlorogenic acid, our data indicated that the bioavailability
and metabolism of these two coffee polyphenols may vary
considerably between individuals, and chlorogenic acid appears
to be more potent in reducing the diabetes risk than caffeic acid.
In conclusion, results of this study suggest that the plasma
concentration of chlorogenic acid may potentially serve as an
indicator of diabetes risk in healthy individuals. Further replica-
tions with large samples of both genders are recommended to
confirm our preliminary findings.
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Table 1. Characteristics of participants, plasma coffee polyphenols
and plasma biomarkers of diabetes risk.
Characteristic Means ± s.d. (n= 57)
Age (years) 52.0± 8.0
Weight (kg) 54.2± 9.0
Body mass index (kg m− 2) 22.5± 4.1
Body fat percentage 24.6± 6.4
Systolic blood pressure (mmHg) 116.8± 12.1
Diastolic blood pressure (mmHg) 71.9± 9.5
Plasma caffeic acid (nM) 54.76± 40.21
Plasma chlorogenic acid (nM) 1.86± 2.01
Glucose (mg dl− 1) 94.18± 36.55
Glycated hemoglobin (%) 5.44± 0.96
Adiponectin (μg ml− 1) 12.65± 4.92
Insulin (μU ml− 1) 4.82± 3.13
C-reactive protein (mg dl− 1) 0.10± 0.21








Glucose 0.1 0.12 − 0.25*
Glycated
hemoglobin
0.16 0.19 − 0.25*
Adiponectin − 0.11 − 0.12 0.1
Insulin 0.12 0.12 − 0.01
C-reactive protein 0.02 0.02 −0.26**
Values are Spearman’s correlation coefficients (n= 57) with *Po0.1,
**Po0.05.
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